INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 336 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,307,267 | +311.9% | 62,889 | +330.7% | 0.09% | +145.7% |
| Q4 2023 | $1,045,652 | -64.6% | 14,600 | -74.3% | 0.04% | -69.0% |
| Q3 2023 | $2,954,962 | -17.7% | 56,728 | +0.1% | 0.11% | -16.3% |
| Q2 2023 | $3,588,661 | -33.6% | 56,675 | -43.2% | 0.14% | -40.0% |
| Q1 2023 | $5,405,849 | +92.7% | 99,831 | +88.3% | 0.22% | +51.0% |
| Q4 2022 | $2,805,236 | +503.3% | 53,009 | +430.1% | 0.15% | +727.8% |
| Q3 2022 | $465,000 | -45.3% | 10,000 | -69.8% | 0.02% | -89.5% |
| Q3 2020 | $850,000 | – | 33,117 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |